Acrivon Therapeutics Inc (ACRV)
9.50
+0.99
(+11.63%)
USD |
NASDAQ |
May 03, 16:00
9.50
0.00 (0.00%)
After-Hours: 20:00
Acrivon Therapeutics Free Cash Flow (Quarterly): -13.52M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -13.52M |
September 30, 2023 | -9.806M |
June 30, 2023 | -9.224M |
March 31, 2023 | -11.38M |
Date | Value |
---|---|
December 31, 2022 | -9.605M |
September 30, 2022 | -6.947M |
June 30, 2022 | -6.898M |
March 31, 2022 | -8.833M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-13.52M
Minimum
Dec 2023
-6.898M
Maximum
Jun 2022
-9.526M
Average
-9.414M
Median
Free Cash Flow (Quarterly) Benchmarks
MyMD Pharmaceuticals Inc | -1.933M |
Vincerx Pharma Inc | -8.019M |
GlycoMimetics Inc | -7.616M |
Immunic Inc | -14.19M |
Skye Bioscience Inc | -3.852M |